PDT Partners, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 211 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,356,946
-24.7%
44,229
-1.6%
0.17%
-31.0%
Q2 2023$1,801,267
-1.8%
44,953
+0.0%
0.25%
-0.4%
Q1 2023$1,834,410
+156.9%
44,950
+252.7%
0.25%
+388.2%
Q3 2021$714,000
-8.3%
12,743
-0.8%
0.05%0.0%
Q2 2021$779,000
-78.7%
12,843
-81.6%
0.05%
-79.5%
Q2 2020$3,658,000
+4.4%
69,713
-33.3%
0.25%
-10.1%
Q1 2020$3,504,000
+11.0%
104,500
+49.9%
0.28%
+42.1%
Q4 2019$3,157,000
+19.0%
69,7000.0%0.20%
+23.4%
Q3 2019$2,653,000
-12.5%
69,7000.0%0.16%
-11.7%
Q2 2019$3,031,000
+14.2%
69,7000.0%0.18%
+19.3%
Q1 2019$2,653,000
-11.6%
69,700
-0.1%
0.15%
-10.7%
Q4 2018$3,001,000
-12.4%
69,760
+0.1%
0.17%
+18.3%
Q3 2018$3,426,000
+6.7%
69,706
-30.4%
0.14%
+16.4%
Q2 2018$3,211,000
+127.1%
100,200
+191.3%
0.12%
+281.2%
Q3 2015$1,414,000
-66.5%
34,396
-27.7%
0.03%
-69.5%
Q1 2015$4,224,000
+391.2%
47,544
+390.1%
0.10%
+23.5%
Q4 2014$860,000
+13.8%
9,700
+24.4%
0.08%
+325.0%
Q3 2014$756,000
+5.4%
7,8000.0%0.02%
+5.3%
Q2 2014$717,000
+29.7%
7,800
-1.3%
0.02%
+46.2%
Q1 2014$553,0007,9000.01%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Tamarack Advisers, LP 550,000$18,442,0006.98%
Gagnon Advisors, LLC 193,860$6,500,0006.06%
GAGNON SECURITIES LLC 407,159$13,652,0004.64%
Spyglass Capital Management LLC 1,190,537$39,919,0004.51%
Paulson & Co. 1,716,727$57,562,0002.20%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,627,521$54,571,0001.73%
Elk Creek Partners, LLC 265,146$8,890,0001.53%
HealthCor Management, L.P. 887,370$29,754,0001.27%
Rock Springs Capital Management LP 900,000$30,177,0001.25%
Lisanti Capital Growth, LLC 108,679$3,644,0001.20%
View complete list of PACIRA PHARMACEUTICALS INC shareholders